オンコリスバイオファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/05/07 | 1,177 | 1,188 | 1,154 | 1,159 | -3 | -0.3% | 256,200 |
| 2021/05/06 | 1,185 | 1,202 | 1,148 | 1,162 | -28 | -2.4% | 258,900 |
| 2021/04/30 | 1,166 | 1,193 | 1,158 | 1,190 | +37 | +3.2% | 332,700 |
| 2021/04/28 | 1,200 | 1,210 | 1,151 | 1,153 | -70 | -5.7% | 483,400 |
| 2021/04/27 | 1,206 | 1,250 | 1,172 | 1,223 | +18 | +1.5% | 734,000 |
| 2021/04/26 | 1,145 | 1,207 | 1,135 | 1,205 | +71 | +6.3% | 560,700 |
| 2021/04/23 | 1,136 | 1,192 | 1,117 | 1,134 | +8 | +0.7% | 640,900 |
| 2021/04/22 | 1,147 | 1,181 | 1,113 | 1,126 | -74 | -6.2% | 1,685,700 |
| 2021/04/21 | 1,144 | 1,330 | 1,109 | 1,200 | +146 | +13.9% | 7,727,200 |
| 2021/04/20 | 1,050 | 1,072 | 1,043 | 1,054 | -4 | -0.4% | 175,500 |
| 2021/04/19 | 1,049 | 1,064 | 1,027 | 1,058 | +7 | +0.7% | 228,100 |
| 2021/04/16 | 1,070 | 1,070 | 1,040 | 1,051 | -20 | -1.9% | 311,400 |
| 2021/04/15 | 1,023 | 1,080 | 1,022 | 1,071 | -101 | -8.6% | 900,700 |
| 2021/04/14 | 1,180 | 1,191 | 1,161 | 1,172 | +4 | +0.3% | 205,900 |
| 2021/04/13 | 1,156 | 1,181 | 1,151 | 1,168 | +9 | +0.8% | 200,800 |
| 2021/04/12 | 1,200 | 1,208 | 1,153 | 1,159 | -39 | -3.3% | 264,800 |
| 2021/04/09 | 1,175 | 1,208 | 1,171 | 1,198 | +15 | +1.3% | 290,300 |
| 2021/04/08 | 1,158 | 1,184 | 1,142 | 1,183 | +20 | +1.7% | 241,600 |
| 2021/04/07 | 1,180 | 1,188 | 1,161 | 1,163 | -25 | -2.1% | 310,000 |
| 2021/04/06 | 1,203 | 1,209 | 1,171 | 1,188 | -18 | -1.5% | 361,900 |
| 2021/04/05 | 1,245 | 1,250 | 1,203 | 1,206 | -44 | -3.5% | 376,000 |
| 2021/04/02 | 1,203 | 1,250 | 1,203 | 1,250 | +42 | +3.5% | 381,400 |
| 2021/04/01 | 1,193 | 1,218 | 1,167 | 1,208 | +29 | +2.5% | 382,600 |
| 2021/03/31 | 1,150 | 1,201 | 1,135 | 1,179 | +28 | +2.4% | 477,400 |
| 2021/03/30 | 1,141 | 1,180 | 1,132 | 1,151 | -9 | -0.8% | 585,400 |
| 2021/03/29 | 1,233 | 1,238 | 1,153 | 1,160 | -56 | -4.6% | 877,900 |
| 2021/03/26 | 1,235 | 1,248 | 1,201 | 1,216 | +9 | +0.7% | 945,700 |
| 2021/03/25 | 1,350 | 1,365 | 1,192 | 1,207 | -192 | -13.7% | 4,285,300 |
| 2021/03/24 | 1,332 | 1,434 | 1,177 | 1,399 | +265 | +23.4% | 12,313,100 |
| 2021/03/23 | 1,215 | 1,215 | 1,131 | 1,134 | -68 | -5.7% | 471,100 |
| 2021/03/22 | 1,187 | 1,226 | 1,175 | 1,202 | +15 | +1.3% | 493,600 |
| 2021/03/19 | 1,147 | 1,194 | 1,131 | 1,187 | +33 | +2.9% | 340,300 |
| 2021/03/18 | 1,155 | 1,161 | 1,134 | 1,154 | -3 | -0.3% | 268,600 |
| 2021/03/17 | 1,140 | 1,162 | 1,122 | 1,157 | +27 | +2.4% | 319,700 |
| 2021/03/16 | 1,102 | 1,130 | 1,082 | 1,130 | +38 | +3.5% | 419,600 |
| 2021/03/15 | 1,077 | 1,166 | 1,062 | 1,092 | +12 | +1.1% | 835,500 |
| 2021/03/12 | 1,086 | 1,094 | 1,066 | 1,080 | +8 | +0.7% | 247,800 |
| 2021/03/11 | 1,048 | 1,076 | 1,029 | 1,072 | +31 | +3% | 219,400 |
| 2021/03/10 | 1,038 | 1,051 | 1,030 | 1,041 | +3 | +0.3% | 289,500 |
| 2021/03/09 | 1,027 | 1,048 | 1,005 | 1,038 | -13 | -1.2% | 320,500 |
| 2021/03/08 | 1,082 | 1,088 | 1,040 | 1,051 | -31 | -2.9% | 266,700 |
| 2021/03/05 | 1,077 | 1,083 | 1,041 | 1,082 | ±0 | ±0% | 202,900 |
| 2021/03/04 | 1,120 | 1,120 | 1,054 | 1,082 | -38 | -3.4% | 353,700 |
| 2021/03/03 | 1,145 | 1,158 | 1,110 | 1,120 | -25 | -2.2% | 240,400 |
| 2021/03/02 | 1,210 | 1,214 | 1,138 | 1,145 | -66 | -5.5% | 418,800 |
| 2021/03/01 | 1,220 | 1,225 | 1,195 | 1,211 | -11 | -0.9% | 135,700 |
| 2021/02/26 | 1,210 | 1,247 | 1,196 | 1,222 | -10 | -0.8% | 136,400 |
| 2021/02/25 | 1,220 | 1,235 | 1,205 | 1,232 | +22 | +1.8% | 147,200 |
| 2021/02/24 | 1,242 | 1,254 | 1,205 | 1,210 | -45 | -3.6% | 180,500 |
| 2021/02/22 | 1,240 | 1,257 | 1,232 | 1,255 | +17 | +1.4% | 124,100 |
1001～
1050
件表示中 / 2808件
類似銘柄と比較する
現在ご覧いただいている「オンコリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| オンコリス | 66,400円 | +3771.0% | - | 0.00% | - | 6.01倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
| ステムリム | 30,800円 | - | - | 0.00% | - | 2.84倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| ＣＡＮＢＡＳ | 93,200円 | - | - | 0.00% | - | 5.96倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| ラクオリア | 62,800円 | +25.1% | - | 0.00% | - | 2.77倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
| Ｃｈｏｒｄｉａ | 22,100円 | - | - | 0.00% | - | 4.70倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム
